期刊文献+

门静脉高压症病人肝移植的相关问题探讨 被引量:2

下载PDF
导出
摘要 随着“肝移植时代”的到来。门静脉高压症的治疗策略和模式必然发生相应的改变,越来越多合并门静脉高压症的终末期肝病病人选择接受肝移植治疗。与此同时,国内供肝短缺矛盾却日益突出。因此,正确理解门静脉高压症病人施行肝移植治疗的问题在当前形势下显得更为重要。
出处 《外科理论与实践》 2009年第1期4-6,共3页 Journal of Surgery Concepts & Practice
  • 相关文献

参考文献1

二级参考文献9

  • 1Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology, 2001, 33: 473-475.
  • 2Trotter JE Brimhall B, Arjal R, et al. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl, 2004, 10: 995-1000.
  • 3Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33: 464-470.
  • 4Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl, 2001, 7: 567-580.
  • 5Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology, 2003, 124: 91-96.
  • 6Freeman RB. Mathematical models and behavior: assessing delta MELD for liver allocation. Am J Transplant, 2004, 4: 1735-1736.
  • 7Giannini E, Botta F, Testa E, et al. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Am J Gastroenterol, 2002, 97: 2855-2860.
  • 8Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003, 52: 134-139.
  • 9中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14012

共引文献8

同被引文献23

  • 1谢建国,严律南.肝移植在门静脉高压症治疗中的地位及围手术期处理[J].中国普通外科杂志,2005,14(6):404-406. 被引量:7
  • 2严佶祺,彭承宏,李宏为.肝移植中门静脉血栓的外科处理[J].中华普通外科杂志,2005,20(8):538-540. 被引量:2
  • 3窦科峰,周景师.从肝移植角度重新认识门静脉高压症的治疗[J].消化外科,2006,5(6):401-402. 被引量:3
  • 4蔡常洁,陆敏强,崇雨田,陈湖岸,陈规划.应用终末期肝病模型对慢性重型肝炎患者的预后评估[J].中华肝脏病杂志,2007,15(6):408-411. 被引量:9
  • 5Merion R M, Wolfe R A, Dykstra D M, et al. Longitudinal assessment of mortality risk among candidates for liver transplantation [J]. Liver Transpl, 2003,9( 1 ) : 12-18.
  • 6Biggins S W, Kim W R, Terrauh N A, et al, Evidence-based incorporation of serum sodium concentration into MELD [J]. Gastroenterology, 2006, 130(6) : 1652-1660.
  • 7Rosemurgy A S, Serafini F M, Zervos E E, et al. Small-diameter prosthetic H-graft portacaval shunt: definitive therapy for variceal bleeding [J]. J Gastrointest Surg, 1998,2(6) :585-591.
  • 8Jamieson N V. Changing perspective in portal vein thrombosis and liver transplantation [ J]. Transplantation, 2000,69 (9) : 1873-1881.
  • 9Seu P, Shackleton C R, Shaked A, et al. Improved result s of liver transplantation in patients with portal vein thrombosis [J]. Arch Surg, 1996, 131 ( 8 ) : 840-844.
  • 10Brown R S, Rush S H, Rosen H R, et al. Liver and intestine transplantation [ J ]. Am J Transplant, 2004,4(9S) : 81-92.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部